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Introduction
Preeclampsia is a hypertensive disorder of pregnancy whose 
etiology though ill-understood has been linked with the 
stimulation	 of	 the	 regulatory	 systems	of	 inflammation	 and	
endothelial function beyond tolerable physiological limits in 
normal pregnancy. This condition still remains a leading cause 
of maternal mortality worldwide and a serious health problem 
that affects the majority of women in the presence of numerous 
preventive and management strategies.[1] Across the globe, the 
incidence rate of preeclampsia currently stands at 2-10%.[2] 
The incidence rate in Ghana is currently pegged around 7%.[3,4]
The etiology of preeclampsia still remains unknown with 
several theories trying to identify the exact cause. However, 
the following theories on the pathogenesis of preeclampsia: 
Placental ischemia, genetics, immune maladaptation, and 
oxidative stress hypotheses have received worldwide 
acclaim.[5] The oxidative stress theory seems to be the 
most popular among the theories and has been linked with 
the lipid abnormalities and vascular dysfunction seen in 
preeclampsia. Consequently, several studies have linked 
dyslipidemia, characterized by abnormal levels of high 
density lipoprotein (HDL), low density lipoprotein (LDL), TC, 
triglycerides (TGs) and very low density lipoprotein (VLDL), 
with an increased risk of preeclampsia.[6-8] Substantial 
variations	 have	 been	 identified	 in	 the	 lipid	 parameters	 of	
preeclamptics compared with normal pregnant women. 
These variations make preeclamptics more vulnerable to 
lipoprotein oxidation a major etiology of this condition. 
Furthermore, abnormalities in lipoprotein metabolism lead 
to cardiovascular consequences and proteinuria, a predictive 
marker of preeclampsia.[9] These arguments emphasize the 
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important role played by dyslipidemia in the pathogenesis of 
preeclampsia and subsequently eclampsia. However, there is 
a paucity of data on the lipid levels of preeclamptics in Ghana 
as earlier studies conducted by Turpin et al., (2008) focused on 
pregnancy induced hypertension (PIH). The aim of this study 
is	to	determine	the	lipid	profile	and	identify	the	association	
between the lipid levels and maternal body mass index (BMI) 
of preeclamptic women in the Cape Coast Metropolis.
Subjects and Methods
Study design/study site
This case-control study was carried out from January to April 
2013, at the maternity wards of the Central Regional Hospital 
and the University of Cape Coast Hospital in the Cape Coast 
Metropolis of the Central Region of Ghana. Cape Coast 
covers a total land mass of 9,826 km2 (2223.9843 acres) with 
an estimated population of 1,805,488 (population census of 
Ghana, 2010).
Study population
A total of 110 pregnant participants comprising 60 preeclamptics 
and 50 healthy normotensive controls matched for age and 
gestational age were recruited using a consecutive sampling 
method. A standard pretested questionnaire was used to 
obtain information on demographic data, family history of 
hypertension, parity, and gravidity. 
Inclusion and exclusion criteria
Participants with gestational age 20 weeks or more, with 
elevated	 blood	 pressure	 (≥140/90	mmHg)	 and	 dipstick	
proteinuria (>++) were recruited as subjects. Healthy pregnant 
women, of similar ages as the cases receiving antenatal care at 
the maternity units of the hospitals were recruited as controls. 
Women with other hypertensive disorders of pregnancy such 
as eclampsia, and other conditions such as diabetes, chronic 
hypertension, autoimmune disease or renal disease were 
excluded.
Ethical consent
Ethical approval was obtained from the Institutional Review 
Board of the University of Cape Coast (IRB/UCC), and the 
Institutional Ethics Committees of the hospitals. Informed 
consent was also obtained from all participants before 
enrollment into the study.
Anthropometric measurements
Patients were made to stand without their sandals, 
bags or anything of significant weight on the weighing 
scale (Hospibrand ZT-120, Huaiyin medical instruments Co. 
Ltd, China) and against the meter rule (Huanan measuring 
tape). The weight was read to the nearest 0.1 kg and recorded. 
The value for the height was recorded to the nearest 0.1 cm 
and then converted to meters. The BMI was calculated using 
formula (weight/height squared) and expressed in kg/m².
Blood pressure measurement
Trained personnel used a mercury sphygmomanometer 
(Accoson, England) and a stethoscope to measure the blood 
pressure of participants in accordance with recommendations 
of the American Heart Association.[10] The procedure was 
repeated for each patient between 5 and 10 min. Mean 
values of duplicate measurements were recorded as the 
blood pressure.
Urine collection and determination of proteinuria
Participants provided 10-20 ml freshly voided early morning 
urine in clean, wide mouth and leak proof containers. Semi 
quantitative proteinuria was immediately assessed using 
dipstick (CYBOW™ DFI Co. Ltd., Gimhae-City, Republic 
of	Korea).	Proteinuria	was	defined	as	the	presence	of	urinary	
protein in concentrations more than 2+ on urine dipstick.
Blood sample
A volume of 5 ml of venous blood samples was collected from 
participants after an overnight fast (8-12 h) and immediately 
transferred into vacutainer plain tubes. The clotted sample was 
centrifuged at 500 g for 5 min and the serum stored at -80°C 
in cryovials until assayed.
Biochemical analysis
Serum TG, total cholesterol (TC), and HDL-C levels were 
estimated by enzymatic techniques with Fortress biochemistry 
kits (Unit 2C Antrim Technology Park, Antrim, BT41 1QS, 
UK) on Labmate 5i semi auto biochemistry analyzer ( Labmate 
(Asia) Pvt. Ltd). Serum VLDL, LDL-C levels (mmol/l) was 
calculated using the Friedewald’s formula: [11]
Statistical analysis
Independent t-test was used to compare mean scores between 
preeclamptics and controls. Chi-square was used to test 
the association between categorical outcome variables. 
Correlations between proteinuria and both clinical and 
biochemical parameters were made using Pearson’s correlation 
coefficient	 test.	The	 odds	 ratio	 of	 the	 association	 between	
preeclampsia and BMI were performed with multivariate 
logistic regression. P < 0.05 were considered as statistically 
significant.	Data	were	analyzed	with	Statistical	Package	for	
Social Sciences (SPSS version 16 SPSS Inc. Chicago, USA).
Results
Sociodemographic and clinical characteristics of study 
participants are shown in Table 1. Women with preeclampsia had 
significantly	higher	BMI	compared	with	the	controls	(P = 0.01). 
Obesity was associated with preeclampsia as preeclamptic 
women were more obese (30.0%; 18/60) than controls 
(4%; 8/50), Mean parity (P = 0.27) and age (P = 0.26) were 
not	 significantly	 different	 in	 preeclamptics	 compared	with	
healthy pregnant controls.
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Table 2 summarizes the clinical and biochemical characteristics 
of the participants. The mean levels of TG, VLDL, LDL-C, 
and	TC	were	 significantly	 higher	 in	 preeclamptic	women	
than in normotensive controls (P = 0.04; 0.02; 0.03; <0.01). 
Though mean HDL-C was higher in controls than in 
preeclamptic women the differences were of no statistical 
significance	(P = 0.83).
Correlation of demographic, clinical, and biochemical 
parameters of participants are shown in Table 3. Proteinuria 
positively correlated with SBP (r = 0.569, P < 0.01), 
DBP (r = 0.429, P < 0.01), LDL (r = 0.377, P < 0.01) 
and TC (r = 0.409, P < 0.01). A similar relationship was 
observed between DBP and TC (r = 0.369, P < 0.01), BMI and 
SBP (r = 0.259, P = 0.02), BMI and DBP (r = 0.234 P = 0.04). 
SBP	was	 significant	 (P < 0.01; 0.02; 0.01) and positively 
associated with DBP, LDL, and TC.
Multivariate logistic regression of factors associated 
with preeclampsia is shown in Table 4. High BMI odds 
ratio (OR = 1.501; CI = 0.926-2.106, P = 0.01) and high 
TG level (OR = 5.026; CI = 0.794-31.818, P = 0.01) were 
significantly	 associated	with	 the	 presence	 of	 preeclampsia.	
However, parity (P = 0.41) and TC (P = 1.00) and were 
not	 significantly	 associated	with	 preeclampsia	 among	 our	
participants.
Discussion
We assessed the association between lipid profile and 
maternal BMI among preeclamptic women in the Cape Coast 
Metropolis. Our results showed that serum lipid levels (TG, 
TC, LDL, and VLDL) were higher among our preeclamptic 
subjects; and hypertriglyceridemia and high BMI were 
independently associated with preeclampsia.
Increased obesity among preeclamptic women has been 
related to implications for prenatal care and supervision of the 
delivery. Participants with preeclampsia were more obese than 
the healthy controls [Table	1]	in	agreement	with	the	finding	of	
Sharami et al.,[12] who alluded that women with preeclampsia 
had higher BMI than controls. The pathophysiological 
mechanism behind the increased BMI in preeclampsia is not 
fully understood though increased insulin resistance and a state 
of	inflammation	associated	with	obesity	are	likely	important	
contributing factors.[13]
Several studies have identified the crucial role played 
by abnormal lipid at different stages of pregnancy in the 
pathogenesis of preeclampsia.[6,7,14] In this study, we observed 
elevated levels of the lipid parameters (TC, TG VLDL, 
and LDL) with reduced levels of HDL in the preeclamptic 
participants compared with the controls [Table 2]. The 
serum concentration of TC was significantly increased 
in the preeclamptics compared with the normal pregnant 
women [Table 2]. This is in conformity with the results of 
earlier studies.[5,15]
Furthermore, our preeclamptics had high levels of TG, 
which corroborates the reports of Gratacós et al.,[9] and 
Evrüke et al.,[16] but contradicts the observations made by 
Turpin et al.,[3] among Ghanaian women with pregnancy 
induced hypertension. Hypertriglyceridemia in preeclampsia 
have been attributed to insulin resistance due to obesity, 
hyperestrogenemia and reduced lipoprotein lipase activity in 
pregnancy.[17,18] Hypertriglyceridemia also leads to increased 
serum levels of VLDL as observed in this study [Table 2] and in 
earlier studies.[19,20] VLDL transports TG in peripheral blood 
thus the resultant high levels of VLDL in hypertriglyceridemia.
Variations in the serum lipid concentrations have been attributed 
to hormonal changes that occur during pregnancy. Serum levels 
of	LDL	were	significantly	elevated	in	the	preeclamptic	women	
compared to normal pregnant controls [Table 2] in agreement 
with the works of Gratacós et al.,[9] and Wakatsuki et al.,[14] 
The	concentration	of	HDL	however	did	not	differ	significantly	
Table 1: Sociodemographic and clinical characteristic of 
study subjects





Age, mean (SD) 29.3 (5.2) 28.0 (5.2) 0.26
Age range (years)





BMI (kg/m²) mean (SD) 29.4 (2.8) 27.0 (2.1) 0.01
BMI n (%)




Parity mean (SD) 2.0 (1.4) 1.6 (1.3) 0.27
Gravida
Primigavida 43 (90.3) 47 (94.0) 0.11
Multigravida 17 (9.7) 3 (6.0)
BMI: Body mass index, SD: Standard deviation








TG 5.1 (1.6) 2.2 (1.6) 0.04
TC 7.6 (2.2) 3.0 (1.8) <0.01
HDL‑C 2.4 (5.9) 2.6 (1.7) 0.83
LDL‑C 3.6 (1.9) 2.1 (1.4) 0.03
VLDL 2.41 (1.0) 1.0 (1.0) 0.02
TG: Triglycerides, TC: Total cholesterol, HDL-C: High-density lipoprotein cholesterol, 
LDL-C: Low-density lipoprotein-cholesterol, VLDL: Very low density lipoprotein
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in the preeclamptics compared to the controls [Table 2]. This 
finding contradicts the high levels observed among PIH 
women in Kumasi, Ghana by Turpin et al.,[3] and the low 
level recorded by Islam et al.,[21] but agrees with the works 
of Wakatsuki et al.,[14] and Lima et al.,[22] who observed 
no changes in HDL-C levels among preeclamptic women 
compared with normal controls. The discrepancies recorded 
in the levels of HDL-C among our participants compared to 
earlier studies could be premised on the fact that whereas 
Turpin et al. studied women with PIH, Islam et al., included 
both preeclamptics and eclamptics in his case control study.
The cause of the increased levels of LDL recorded among 
our participants remains unclear as no correlation existed 
between maternal BMI and LDL-C [Table 2]. However, studies 
conducted by Salameh and Mastrogiannis,[23] have associated 
increased LDL-C levels to elevated estrogen and progesterone 
levels in preeclampsia.
Our	findings	 from	 correlation	 studies	 [Table	 3]	 confirmed	
suggestions that LDL, TC, and HDL may be involved in 
the endothelial damage associated with the pathogenesis of 
preeclampsia. Endothelial dysfunction, mostly associated 
with oxidation of LDL, leads to the formation of glomerular 
lesions and subsequently proteinuria, which is associated with 
preeclampsia as well as give an indication of its severity.
Obesity and abnormal lipid levels, especially TG 
contribute to the development of preeclampsia, which 
is characterized by proteinuria and high blood pressure, 
through endothelial dysfunction.[22] When we controlled 
for age and other confounders through multivariate logistic 
regression analysis the preeclamptic participants were 
obese (OR = 1.501; CI = 0.926–2.106; P = 0.01) and had 
hypertriglyceridemia (OR = 5.026; CI = 0.794–31.818; 
P = <0.01) [Table 4]. The risk posed by elevated TG levels 
in the development of preeclampsia as reported in this study 
confirms	earlier	evidence	in	cohort	studies	which	indicated	that	
the risk of preeclampsia was four times higher in women with 
elevated levels of TG, than in women with normal TG.[24] It also 
reaffirmed	the	argument	that	maternal	obesity	is	independently	
associated with the development of placental endothelial 
dysfunction and ultimately preeclampsia.[12]
The variation in study design coupled with the small sample 
employed could explain the insignificant differences in 
Table 3: Correlation of demographic, clinical, and biochemical parameters of participants
Variable BMI SBP DBP Parity LDL HDL TC TG VLDL PRT
BMI
R 1 0.259* 0.234* −0.009 0.149 −0.002 0.158 0.159 0.158 0.105
P value 0.02 0.04 0.94 0.18 0.99 0.16 0.16 0.16 0.35
SBP
R 1 0.879** 0.044 0.255* 0.077 0.283* −0.049 −0.049 0.569**
P value <0.01 0.70 0.02 0.49 0.01 0.66 0.66 <0.01
DBP
R 1 0.048 0.222* 0.028 0.369** −0.044 −0.044 0.429**
P value 0.67 0.05 0.81 <0.01 0.70 0.70 <0.01
Parity
R 1 −0.067 0.152 −0.179 0.054 0.055 −0.020
P value 0.55 0.18 0.11 0.63 0.63 0.86
LDL
R 1 −0.243* 0.624** 0.140 0.140 0.377**
P value 0.03 <0.01 0.21 0.21 <0.01
HDL
R 1 −0.094 −0.057 −0.057 −0.574
P value 0.40 0.61 0.61 0.01
TC
R 1 0.018 0.018 0.409**
P value 0.87 0.83 <0.01
TG
R 1 0.999** 0.049







*Correlation=Statistically significant at P<0.05, **Correlation=Statistically significant at P<0.01, r=Correlation coefficient. PRT: Proteinuria, BMI: Body mass index, TC: Total cholesterol, 
TG: Triglycerides, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, LDL: Low-density lipoprotein, HDL: High-density lipoprotein, VLDL: Very low density lipoprotein
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the parity of the cases compared to the controls. Second, the 
single determination of lipids as employed in this study instead 
of serial measurements in the course of the pregnancy as 
employed in longitudinal studies may lead to misleading data.
Conclusion
Lipid abnormalities mostly elevated levels of TG, TC, LDL, 
and VLDL are present in preeclamptics. The high TG levels and 
BMI are associated with preeclampsia during pregnancy. Thus, 
it is incumbent on health caregivers to ensure that women of 
childbearing age adopt healthy lifestyles so as to control their 
weight and lipid levels, especially TGs to reduce their risk of 
developing preeclampsia.
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OR (95% CI) P value
High BMI 0.334 1.501 (0.926‑2.106) 0.01
Parity 0.267 1.306 (0.691‑2.469) 0.41
High TG 1.615 5.026 (0.794‑31.818) 0.01
TC 21.202 0 (0.00‑0.00) 1.00
OR: Odd ratio, TC: Total cholesterol, TG: Triglycerides, BMI: Body mass index, 
CI: Confidence interval
